Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078767 · ClinicalTrials.gov registry record · Phase 3
Pharmacologic Treatment of PTSD in Sexually Abused Children
A Phase 3 study, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT00078767 is a Phase 3 study that has completed, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 24 participants.
The verdict
NCT00078767, a Phase 3 study, has completed, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will evaluate the benefit of adding sertraline (Zoloft®) to Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) for sexually abused children who have Posttraumatic Stress Disorder (PTSD).
Interventions
- DRUG Placebo Oral Tablet
- BEHAVIORAL Trauma-Focused Cognitive Behavioral Therapy
- DRUG Sertraline Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2001-04 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00078767
The ClinicalTrials.gov registry entry for NCT00078767 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo Oral Tablet is the first listed.
NCT00078767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00078767 about?
NCT00078767 is a clinical study titled "Pharmacologic Treatment of PTSD in Sexually Abused Children". This study will evaluate the benefit of adding sertraline (Zoloft®) to Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) for sexually abused children who have Posttraumatic Stress Disorder (PTSD).
What is the current status of trial NCT00078767?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2001-04. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00078767?
The interventions under investigation include: Placebo Oral Tablet (DRUG), Trauma-Focused Cognitive Behavioral Therapy (BEHAVIORAL), Sertraline Pill (DRUG).
Who is sponsoring clinical trial NCT00078767?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.